The following is a summary of "Oncological outcomes after vaginal and robotic-assisted radical trachelectomy in patients with ...

Agnes Kathrine Lie, MD, PhD, Department of Pathology, and Gunnar Kristensen ... available HPV tests in the Norwegian Coordinated Cervical Cancer Screening Program, financially supported by ...

Prioritising personal whims over tested science, ignoring vaccine-preventable diseases, and devaluing international ...

Pan-Africa Conference on Lung Cancer has kicked off in Accra, Ghana with global experts calling for increased research, and efforts to improve care and prevent lung cancer deaths in Africa.Researchers ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

Cervical cancer is one of the most common cancers, and it develops due to abnormal cell growth in the cervix, triggered by persistent infection with the human papillomavirus (HPV). The common ...

Dr. Ritu Salani discusses how patients with cervical cancer can advocate for their health and collaborate with their medical team to ensure the best care.

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Cervical cancer, caused by Human Papilloma Virus (HPV), is not hereditary, and HPV infection doesn't always lead to cancer. Pap smears are crucial for early detection, and HPV vaccines can prevent ...